Lux Biosciences, Inc. - Management

Ulrich Grau, Ph.D.

Founder, President & Chief Executive Officer

Dr. Grau is the President and Chief Executive Officer of
Lux Biosciences Inc. Dr. Grau brings 25 years of experience from the biotechnology and pharmaceutical industry to the company. His extensive expertise in the healthcare field includes general and
R&D management, corporate strategy and strategic alliances, and the development of new products and technologies for a variety
of diseases.

Dr. Grau served as Enzon’s Chief Scientific Officer from 2002 to January 2005. In this role, he upgraded Enzon’s R&D capabilities and built a rich portfolio of projects in all stages of development, based on Enzon’s macromolecular engineering technologies (Single Chain Antibodies [SCAs] and PEGylation) and based on partnering. The areas of therapeutic focus included oncology and immunology, as well as viral and fungal infections.

Prior to joining Enzon Dr. Grau served as President of Research and Development and member of the Executive Board at BASF Pharma/ Knoll where he directed a global R&D organization and significantly advanced and expanded the Company’s product portfolio. This included therapies for autoimmune diseases, obesity, arrhythmia, sepsis, severe pain, and most notably, a human antibody directed against TNF-α (adalimumab, Humira^®) for the treatment of rheumatoid arthritis and other autoimmune diseases.

Previously, Dr. Grau served as Senior Vice President and R&D Integration Officer of Aventis Pharma, and as SVP Global Product Realization at Hoechst Marion Roussel, where he directed the company’s global late-stage product development activities with a portfolio of projects ranging from diabetes, infectious diseases, oncology, neurology, osteoporosis, cardiology, rheumatology, and hormone replacement therapies, and a budget of $ 940 million. During 1996-97, Dr. Grau was CEO of Hoechst Marion Roussel in the Netherlands, responsible for the entire commercial infrastructure of this subsidiary. Insulin Glargine (Lantus^®) is based on his inventions at the beginning of his career at Hoechst.

Dr. Grau received his Ph.D. in chemistry and biochemistry from the University of Stuttgart and spent three years as a post-doctoral fellow at Purdue University in the field of protein crystallography.